Clinical Trial: A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07069972) titled 'A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.' on June 13.

Brief Summary: The objective of this observational study is to compare the efficacy and safety of telitacicept versus belimumab in systemic lupus erythematosus (SLE) patients aged 18-65 years. The primary questions it aims to answer are:

* In the overall SLE population: What are the SRI-4 response rates for both drugs?

* In the lupus nephritis subgroup: What are the major renal response rates for both drugs?

Participants will autonomously select t...